Prevention of advanced glycation end products accumulation in the STZ-induced model of diabetes has been reported to inhibit overexpression of IGF1, IGFBP-1, and IGFBP-4 mRNAs, suggesting the role of glycation end products in activation of IGF1 renal expression in diabetes mellitus [138]. Here, IGFBP1 is linked to diabetes mellitus.